Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of DC071 Mouthwash (0.2% Chlorhexidine Digluconate) in Peri-surgical Care for Preventing Alveolar Osteitis After Third Molar Extraction

NCT02382809 is registered in ClinicalTrials.gov with Pierre Fabre Medicament as lead sponsor.

NCT NCT02382809
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02382809 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of DC071 Mouthwash (0.2% Chlorhexidine Digluconate) in Peri-surgical Care for Preventing Alveolar Osteitis After Third Molar Extraction
Lead sponsor
Pierre Fabre Medicament
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2015
Completion date
February 29, 2016
Enrollment
414 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

alveolar osteitis